Driehaus Capital Management’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162M Sell
1,920,800
-262,904
-12% -$19.1M 1.19% 7
2025
Q4
$165M Buy
2,183,704
+25,202
+1% +$1.59M 1.12% 7
2025
Q3
$85.8M Sell
2,158,502
-152,253
-7% -$5.81M 0.61% 39
2025
Q2
$100M Sell
2,310,755
-28,808
-1% -$1.1M 0.8% 22
2025
Q1
$87.4M Sell
2,339,563
-265,747
-10% -$10.3M 0.84% 21
2024
Q4
$118M Buy
2,605,310
+71,703
+3% +$3.66M 0.97% 16
2024
Q3
$149M Buy
2,533,607
+415,737
+20% +$19.9M 1.28% 10
2024
Q2
$83.3M Buy
2,117,870
+54,107
+3% +$2.63M 0.81% 27
2024
Q1
$137M Buy
2,063,763
+734,699
+55% +$32.1M 1.37% 9
2023
Q4
$37.1M Sell
1,329,064
-10,211
-0.8% -$205K 0.45% 63
2023
Q3
$28.5M Buy
+1,339,275
New +$29.5M 0.37% 83

Other funds holding APGE